- Published at
- by gurufocus.com
mixed
mixed
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension
BOSTON, March 27, 2025 (GLOBE